69639-106 : Akynzeo Intravenous Injection
NDC: | 69639-106 |
Labeler: | Helsinn Therapeutics (U.s.), Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Akynzeo |
Dosage Form: | Intravenous Injection |
Application #: | NDA210493 |
Rev. Date: |
NDC Package Codes:
- 69639-106-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (69639‑106‑01) / 20 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Fosnetupitant
- Palonosetron Hydrochloride
Dosage Strength:
- 260 mg/20mL
- .28 mg/20mL
Pharmaceutical Classes:
- Serotonin 3 Receptor Antagonists [MoA]
- Serotonin-3 Receptor Antagonist [EPC]
Related Products:
Based on records with the same trade name.- 69639-101 Akynzeo Oral Capsule by Helsinn Therapeutics (U.s.), Inc.
- 69639-102 Akynzeo Intravenous Injection by Helsinn Therapeutics (U.s.), Inc.
- 69639-105 Akynzeo Intravenous Injection by Helsinn Therapeutics (U.s.), Inc.
- 62856-796 Akynzeo Oral Capsule by Eisai Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 69639-105Next: 69639-120 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.